(Total Views: 460)
Posted On: 02/22/2021 11:15:36 AM
Post# of 149219
Re: thriftycents #79227
Here you go:
“About Coronavirus Disease 2019
CytoDyn completed its Phase 2 clinical trial (CD10) for COVID-19, a double-blinded, randomized clinical trial for mild-to-moderate patients in the U.S. which produced statistically significant results for NEWS2. CytoDyn completed enrollment of 390 patients in its Phase 2b/3 randomized clinical trial for the severe-to-critically ill COVID-19 population and expects to release results in early February 2021 .”
https://www.cytodyn.com/newsroom/press-releas...and-health
“About Coronavirus Disease 2019
CytoDyn completed its Phase 2 clinical trial (CD10) for COVID-19, a double-blinded, randomized clinical trial for mild-to-moderate patients in the U.S. which produced statistically significant results for NEWS2. CytoDyn completed enrollment of 390 patients in its Phase 2b/3 randomized clinical trial for the severe-to-critically ill COVID-19 population and expects to release results in early February 2021 .”
https://www.cytodyn.com/newsroom/press-releas...and-health
(3)
(0)Scroll down for more posts ▼
